HMPL-506
Phase 1Recruiting 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hematological Malignancies
Conditions
Hematological Malignancies
Trial Timeline
May 27, 2024 → Dec 8, 2027
NCT ID
NCT06387082About HMPL-506
HMPL-506 is a phase 1 stage product being developed by HUTCHMED for Hematological Malignancies. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06387082. Target conditions include Hematological Malignancies.
What happened to similar drugs?
0 of 1 similar drugs in Hematological Malignancies were approved
Approved (0) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
15
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06387082 | Phase 1 | Recruiting |
Competing Products
20 competing products in Hematological Malignancies